Cell and Gene Therapy Insights

CELL AND GENE THERAPY INSIGHTS

November 2024

Cell and Gene Therapy Insights Vol 10 Issue 10
View Issue

Vol 10 Issue 10

Spotlight: Cell therapy downstream processing and analytics

View Spotlight

Supply Chain focus: Securing the supply chain 2024

View Focus

Latest Articles

A massive thank you to all our Peer Reviewers in 2024

A massive thank you to all our Peer Reviewers in 2024

13 December
Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Nathaniel Clark
13 December
Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Isaak Decoene, Ioannis Papantoniou
12 December
Navigating the complexities of AAV and lentiviral vector characterization

Navigating the complexities of AAV and lentiviral vector characterization

Susumu Uchiyama
12 December
Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Sharon Rouw
10 December
History and progress in viral vector particle size distribution analysis

History and progress in viral vector particle size distribution analysis

Steven Berkowitz
9 December
Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

9 December
Preparing for success in gene therapy purification

Preparing for success in gene therapy purification

X Fu, A Sharma, A D Tustian et al.
5 December
Pioneering quality control in biomanufacturing of cell and gene therapies

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez
5 December

Channel content

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Nathaniel Clark
13 December
Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Isaak Decoene, Ioannis Papantoniou
12 December
Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Sharon Rouw
10 December
View channel
Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Nathaniel Clark
13 December
Navigating the complexities of AAV and lentiviral vector characterization

Navigating the complexities of AAV and lentiviral vector characterization

Susumu Uchiyama
12 December
History and progress in viral vector particle size distribution analysis

History and progress in viral vector particle size distribution analysis

Steven Berkowitz
9 December
View channel
Navigating the complexities of AAV and lentiviral vector characterization

Navigating the complexities of AAV and lentiviral vector characterization

Susumu Uchiyama
12 December
Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

Sharon Rouw
10 December
History and progress in viral vector particle size distribution analysis

History and progress in viral vector particle size distribution analysis

Steven Berkowitz
9 December
View channel
Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Hari Pujar
26 September
Navigating the European landscape of advanced therapy funding and commercialization

Navigating the European landscape of advanced therapy funding and commercialization

Dmitry A Kuzmin
2 September
Driving digital innovation for supply chain orchestration in cell and gene therapy

Driving digital innovation for supply chain orchestration in cell and gene therapy

Christian Fuchs
27 August
View channel
Pioneering quality control in biomanufacturing of cell and gene therapies

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez
5 December
Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann
4 December
Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Damian Marshall, Kayleigh Thirlwell
2 December
View channel
Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann
4 December
Operations strategy for a scalable CGT supply chain: key CXO insights

Operations strategy for a scalable CGT supply chain: key CXO insights

Shesh Sharma, Tim Sirichoke, Edward Ballesteros
2 December
Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Raj Joshi
4 November
View channel
Looking to a future of multiplex cell engineering

Looking to a future of multiplex cell engineering

Marco Alessandrini
11 January
Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Zhenghong Gao
5 January
Biological & operational considerations for iPSC-derived cell production

Biological & operational considerations for iPSC-derived cell production

A Mogen, A Fernandez-Perez, J Wang et al.
20 December 2023
View channel